Reversal of adriamycin resistance by lonidamine in a human breast cancer cell line.
Citro
G
G
Laboratory of Experimental Chemotherapy, Regina Elena Institute for Cancer Research, Rome, Italy.
Cucco
C
C
Verdina
A
A
Zupi
G
G
D000970:Antineoplastic Agents / Q000494:pharmacology*; D001692:Biological Transport; D001943:Breast Neoplasms; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D004317:Doxorubicin / Q000378:metabolism / Q000494:pharmacology*; D004351:Drug Resistance / Q000502:physiology*; D004357:Drug Synergism; D005260:Female; D006801:Humans; D007191:Indazoles / Q000494:pharmacology*; D007700:Kinetics
D000970:Antineoplastic Agents; D007191:Indazoles; D004317:Doxorubicin; C016371:lonidamine